舒格利单抗联合化疗一线治疗晚期胃癌的药物经济学评价
翟凤, 李洪洋, 魏青青, 涂秋波, 茆健鹏
Cost‑utility analysis of sugemalimab plus chemotherapy as first‑line treatment for advanced gastric cancer
ZHAI Feng, LI Hongyang, WEI Qingqing, TU Qiubo, MAO Jianpeng
中国医院药学杂志
.
2026, (6): 698
-703
.
DOI: 10.13286/j.1001-5213.2026.06.13
